Gordon L. Archer

10.8k total citations · 2 hit papers
103 papers, 7.7k citations indexed

About

Gordon L. Archer is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Gordon L. Archer has authored 103 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Infectious Diseases, 51 papers in Molecular Biology and 30 papers in Epidemiology. Recurrent topics in Gordon L. Archer's work include Antimicrobial Resistance in Staphylococcus (83 papers), Bacterial biofilms and quorum sensing (38 papers) and Bacterial Identification and Susceptibility Testing (29 papers). Gordon L. Archer is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (83 papers), Bacterial biofilms and quorum sensing (38 papers) and Bacterial Identification and Susceptibility Testing (29 papers). Gordon L. Archer collaborates with scholars based in United States, France and United Kingdom. Gordon L. Archer's co-authors include Michael W. Climo, Kent Crossley, Mark E. Rupp, J L Johnston, Debra M. Niemeyer, Roberto L. Patron, Michael J. Noto, George A. Jacoby, Adriana E. Rosato and Franklin H. Epstein and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Gordon L. Archer

103 papers receiving 7.1k citations

Hit Papers

Staphylococcus aureus: A Well–Armed Pathogen 1996 2026 2006 2016 1998 1996 100 200 300 400 500

Peers

Gordon L. Archer
Kavindra V. Singh United States
Holger Rohde Germany
Jodi A. Lindsay United Kingdom
R D Arbeit United States
Henrik Westh Denmark
D. Ashley Robinson United States
P A Mickelsen United States
Dag Harmsen Germany
Binh An Diep United States
Kavindra V. Singh United States
Gordon L. Archer
Citations per year, relative to Gordon L. Archer Gordon L. Archer (= 1×) peers Kavindra V. Singh

Countries citing papers authored by Gordon L. Archer

Since Specialization
Citations

This map shows the geographic impact of Gordon L. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon L. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon L. Archer more than expected).

Fields of papers citing papers by Gordon L. Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon L. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon L. Archer. The network helps show where Gordon L. Archer may publish in the future.

Co-authorship network of co-authors of Gordon L. Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon L. Archer. A scholar is included among the top collaborators of Gordon L. Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon L. Archer. Gordon L. Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Justet, A., et al.. (2023). Inhaled FGF19 Therapy in Pulmonary Fibrosis. A4708–A4708. 2 indexed citations
2.
Planet, Paul J., Apurva Narechania, Liang Chen, et al.. (2016). Architecture of a Species: Phylogenomics of Staphylococcus aureus. Trends in Microbiology. 25(2). 153–166. 49 indexed citations
3.
Boundy, Sam, Martin K. Safo, Lei Wang, et al.. (2012). Characterization of the Staphylococcus aureus rRNA Methyltransferase Encoded by orfX, the Gene Containing the Staphylococcal Chromosome Cassette mec (SCCmec) Insertion Site. Journal of Biological Chemistry. 288(1). 132–140. 53 indexed citations
4.
Wang, Lei & Gordon L. Archer. (2010). Roles of CcrA and CcrB in Excision and Integration of Staphylococcal Cassette Chromosome mec , a Staphylococcus aureus Genomic Island. Journal of Bacteriology. 192(12). 3204–3212. 55 indexed citations
5.
Goldstein, F. W., Jiřı́ Perůtka, Arabela Cuirolo, et al.. (2007). Identification and Phenotypic Characterization of a β-Lactam-Dependent, Methicillin-Resistant Staphylococcus aureus Strain. Antimicrobial Agents and Chemotherapy. 51(7). 2514–2522. 18 indexed citations
6.
Fox, Paige M., Michael W. Climo, & Gordon L. Archer. (2007). Lack of Relationship between Purine Biosynthesis and Vancomycin Resistance in Staphylococcus aureus : a Cautionary Tale for Microarray Interpretation. Antimicrobial Agents and Chemotherapy. 51(4). 1274–1280. 18 indexed citations
7.
Fowler, Vance G., Charlotte Nelson, Lauren M. McIntyre, et al.. (2007). Potential Associations between Hematogenous Complications and Bacterial Genotype inStaphylococcus aureusInfection. The Journal of Infectious Diseases. 196(5). 738–747. 121 indexed citations
8.
Safo, Martin K., Tzu‐Ping Ko, Faik N. Musayev, et al.. (2006). Structure of the MecI repressor fromStaphylococcus aureusin complex with the cognate DNA operator ofmec. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 62(4). 320–324. 20 indexed citations
9.
Archer, Gordon L., et al.. (2002). Combinations of Lysostaphin with β-Lactams Are Synergistic against Oxacillin-Resistant Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy. 46(6). 2017–2020. 56 indexed citations
10.
Archer, Gordon L., et al.. (2000). Phenotypic Expression of Oxacillin Resistance in Staphylococcus epidermidis : Roles of mecA Transcriptional Regulation and Resistant-Subpopulation Selection. Antimicrobial Agents and Chemotherapy. 44(6). 1616–1623. 25 indexed citations
11.
Crossley, Kent & Gordon L. Archer. (1996). The staphylococci in human disease. Churchill Livingstone eBooks. 494 indexed citations breakdown →
12.
Archer, Gordon L., Debra M. Niemeyer, Jane A. Thanassi, & Michael J. Pucci. (1994). Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrobial Agents and Chemotherapy. 38(3). 447–454. 116 indexed citations
13.
Archer, Gordon L. & Debra M. Niemeyer. (1994). Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends in Microbiology. 2(10). 343–347. 133 indexed citations
14.
Archer, Gordon L., Gary V. Doern, Mary Jane Ferraro, et al.. (1993). RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagnostic Microbiology and Infectious Disease. 16(3). 223–226. 32 indexed citations
15.
Thomas, William D. & Gordon L. Archer. (1992). Mobilization of recombinant plasmids from Staphylococcus aureus into coagulase negative Staphylococcus species. Plasmid. 27(2). 164–168. 13 indexed citations
16.
Archer, Gordon L.. (1991). Alteration of Cutaneous Staphylococcal Flora as a Consequence of Antimicrobial Prophylaxis. Clinical Infectious Diseases. 13(Supplement_10). S805–S809. 61 indexed citations
17.
Johnston, J L, et al.. (1989). Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrobial Agents and Chemotherapy. 33(4). 460–466. 153 indexed citations
18.
Projan, Steven J. & Gordon L. Archer. (1989). Mobilization of the relaxable Staphylococcus aureus plasmid pC221 by the conjugative plasmid pGO1 involves three pC221 loci. Journal of Bacteriology. 171(4). 1841–1845. 89 indexed citations
19.
Archer, Gordon L.. (1988). Molecular epidemiology of multiresistant Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy. 21(suppl C). 133–138. 47 indexed citations
20.
Coudron, P E, J L Johnston, & Gordon L. Archer. (1987). In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis. Journal of Antimicrobial Chemotherapy. 20(4). 505–511. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026